Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis.

PubWeight™: 1.33‹?› | Rank: Top 10%

🔗 View Article (PMC 46534)

Published in Proc Natl Acad Sci U S A on May 15, 1993

Authors

W G Hoeck1, C S Ramesha, D J Chang, N Fan, R A Heller

Author Affiliations

1: Institute of Biochemistry and Cell Biology, Syntex Research, Palo Alto, CA 94304.

Articles citing this

Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol (1994) 1.72

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry (2009) 1.64

TNF ligands and receptors--a matter of life and death. Br J Pharmacol (2002) 1.57

A novel signaling mechanism between gas and blood compartments of the lung. J Clin Invest (2000) 1.34

Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am J Pathol (1998) 1.30

Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J Virol (1997) 1.08

Neuroinflammation and synaptic loss. Neurochem Res (2012) 1.06

The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane. J Virol (1995) 1.05

The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J Virol (1996) 1.02

Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene. Nucleic Acids Res (1994) 1.02

Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer. Clin Cancer Res (2008) 1.01

Retracted Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats. J Cereb Blood Flow Metab (2010) 0.97

Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes. Biochem J (2003) 0.93

Lipopolysaccharide induced apoptosis of rat pancreatic acinar cells. Gut (1996) 0.90

Interleukin 1 alpha causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J Clin Invest (1994) 0.90

Dexamethasone down-regulates the 85 kDa phospholipase A2 in mouse macrophages and suppresses its activation. Biochem J (1995) 0.88

Interferon-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three. EMBO J (1996) 0.86

Role of cytosolic phospholipase A2 in arachidonic acid release of rat-liver macrophages: regulation by Ca2+ and phosphorylation. Biochem J (1995) 0.86

Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J Inflamm Res (2010) 0.86

Retracted Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites. Neurochem Res (2010) 0.86

Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction. J Exp Med (2003) 0.86

Identification of genes involved in ceramide-dependent neuronal apoptosis using cDNA arrays. Genome Biol (2002) 0.85

Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway. Am J Physiol Heart Circ Physiol (2012) 0.82

Phospholipase A2 isoforms are altered in chronic pancreatitis. Ann Surg (1998) 0.82

Cytosolic phospholipase A2 gene expression in rat mesangial cells is regulated post-transcriptionally. Biochem J (1994) 0.81

Coordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging. PLoS One (2014) 0.81

Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells. Proc Natl Acad Sci U S A (1995) 0.80

Phospholipase A2 isoforms in acute pancreatitis. Ann Surg (2001) 0.80

RhoA/Rho Kinase Mediates Neuronal Death Through Regulating cPLA2 Activation. Mol Neurobiol (2016) 0.79

Arachidonic acid mobilization is suppressed during mitosis: role of cytosolic phospholipase A2 activation. Biochem J (1995) 0.78

Effects of the inhibition of cytosolic phospholipase A(2)α in non-small cell lung cancer cells. J Cancer Res Clin Oncol (2012) 0.78

Interaction of arachidonic acid with electrogenic properties of mouse chemosensory neurons. Eur J Med Res (2010) 0.77

Multiple C-terminal serine phosphorylation accompanies both protein kinase C-dependent and -independent activation of cytosolic 85 kDa phospholipase A2 in macrophages. Biochem J (1997) 0.77

Identification of a 27 bp 5'-flanking region element responsible for the low level constitutive expression of the human cytosolic phospholipase A2 gene. Nucleic Acids Res (1995) 0.75

Regulatory role of cytosolic phospholipase A2 alpha in the induction of CD40 in microglia. J Neuroinflammation (2017) 0.75

Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1 alpha and TNF-alpha. Arch Dermatol Res (1996) 0.75

Corticosterone suppresses IL-1β-induced mPGE2 expression through regulation of the 11β-HSD1 bioactivity of synovial fibroblasts in vitro. Exp Ther Med (2017) 0.75

Articles cited by this

The steroid and thyroid hormone receptor superfamily. Science (1988) 25.68

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science (1987) 8.36

cPLA2 is phosphorylated and activated by MAP kinase. Cell (1993) 6.61

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell (1991) 5.84

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell (1990) 5.59

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell (1990) 4.58

How is the level of free arachidonic acid controlled in mammalian cells? Biochem J (1982) 3.96

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci U S A (1991) 3.76

Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: implications for their mechanism of activation. Proc Natl Acad Sci U S A (1991) 3.31

Intracellular phospholipases A. Biochim Biophys Acta (1980) 3.29

Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem (1991) 3.06

Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci U S A (1992) 2.55

The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats. Cell (1986) 2.36

Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase. Cell (1986) 2.34

Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science (1992) 2.13

A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J Biol Chem (1990) 2.10

Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. J Biol Chem (1990) 1.99

Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci U S A (1990) 1.87

The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell (1992) 1.80

The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem (1991) 1.79

Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem (1991) 1.70

Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem (1991) 1.66

Identification and characterization of a hormonally regulated form of phospholipase A2 in rat renal mesangial cells. J Biol Chem (1988) 1.56

The molecular action of tumor necrosis factor-alpha. Eur J Biochem (1991) 1.52

Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene C4 production. Cell (1992) 1.44

Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem J (1988) 1.42

Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis. J Immunol (1988) 1.41

Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem (1991) 1.32

TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite. EMBO J (1991) 1.19

Signal transduction by interferon-alpha through arachidonic acid metabolism. Science (1991) 1.17

Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem (1992) 1.17

Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol Cell Biol (1991) 1.16

Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem (1990) 1.15

Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription. Proc Natl Acad Sci U S A (1987) 1.13

Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. J Immunol (1991) 1.11

Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci U S A (1990) 1.08

Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. Cancer Res (1990) 1.06

Resistance to killing by tumor necrosis factor in an adipocyte cell line caused by a defect in arachidonic acid biosynthesis. J Biol Chem (1991) 1.03

Interleukin-1 beta, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochem Biophys Res Commun (1991) 1.00

Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-alpha is mediated by lipoxygenase metabolites of arachidonic acid. Biochem Biophys Res Commun (1992) 0.99

Human tumour necrosis factor-alpha (TNF-alpha) directly stimulates arachidonic acid release in human neutrophils. Immunology (1990) 0.97

Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochem Biophys Res Commun (1991) 0.85

A novel mechanism of glucocorticosteroid (GC) action in suppression of phospholipase A2 (PLA2) activity stimulated by Ca2+ ionophore A23187: induction of protein phosphatases. Adv Prostaglandin Thromboxane Leukot Res (1991) 0.78

Articles by these authors

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell (1991) 5.84

Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol (1998) 4.25

Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A (2000) 3.47

Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem (1997) 2.18

Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A (1985) 2.16

The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell (1992) 1.80

Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem (1984) 1.78

Cloning of the amino-terminal and 5'-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. J Biol Chem (1998) 1.76

Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J Biol Chem (1996) 1.76

An unusually small gene required for sporulation by Bacillus subtilis. Mol Microbiol (1993) 1.62

Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol (1997) 1.53

Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr (1997) 1.33

TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite. EMBO J (1991) 1.19

Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b). Br J Pharmacol (1997) 1.15

3-Hydroxy-3-methylglutaryl coenzyme A reductase from rat liver. Its purification, properties, and immunochemical studies. J Biol Chem (1976) 1.13

Three cases of phycomycosis in dogs. Vet Med Small Anim Clin (1971) 1.12

CCAAT/enhancer binding protein expression is rapidly extinguished in TA1 adipocyte cells treated with tumor necrosis factor. Mol Endocrinol (1992) 1.08

The 5-HT7 receptor: orphan found. Trends Pharmacol Sci (1997) 1.07

Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther (1999) 1.06

Multiple forms and cellular localization of Drosophila DNA topoisomerase II. J Biol Chem (1986) 1.06

Resistance to killing by tumor necrosis factor in an adipocyte cell line caused by a defect in arachidonic acid biosynthesis. J Biol Chem (1991) 1.03

Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid. J Biol Chem (1997) 1.02

Overexpression of and RNA interference with the CCAAT enhancer-binding protein on long-term facilitation of Aplysia sensory to motor synapses. Learn Mem (2001) 1.02

Solubilization and partial purification of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochem Biophys Res Commun (1973) 1.01

Immunotitration of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in various physiological states. Proc Natl Acad Sci U S A (1979) 1.00

Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-alpha is mediated by lipoxygenase metabolites of arachidonic acid. Biochem Biophys Res Commun (1992) 0.99

Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J Biol Chem (1988) 0.99

Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol (1999) 0.99

Cloning and functional characterization of a Caenorhabditis elegans muscarinic acetylcholine receptor. Receptors Channels (1999) 0.98

Cloning and expression of a G protein-linked acetylcholine receptor from Caenorhabditis elegans. J Neurochem (1999) 0.98

CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem (1998) 0.96

Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid. J Biol Chem (1986) 0.96

3-Hydroxy-3-methylglutaryl coenzyme A reductase in isolated villous and crypt cells of the rat ileum. J Lipid Res (1977) 0.93

Changes in the lipid composition and physical properties of Tetrahymena ciliary membranes following low-temperature acclimation. Biochemistry (1982) 0.92

Immunoassay employing surface-enhanced Raman spectroscopy. Anal Biochem (1989) 0.92

Cold stress induces in situ phospholipid molecular species changes in cell surface membranes. Biochim Biophys Acta (1983) 0.92

On the formation of alpha-hydroxy fatty acids. Evidence for a direct hydroxylation of nonhydroxy fatty acid-containing sphingolipids. J Biol Chem (1984) 0.91

Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3. Virology (1995) 0.90

Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23. Virology (1993) 0.90

Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. Curr Med Res Opin (2006) 0.90

Reversible cold inactivation of microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase from rat liver. J Biol Chem (1974) 0.88

Chimeric tumor necrosis factor-TrkA receptors reveal that ligand-dependent activation of the TrkA tyrosine kinase is sufficient for differentiation and survival of PC12 cells. Proc Natl Acad Sci U S A (1993) 0.88

Differential regulation of human neutrophil FcgammaRIIa (CD32) and FcgammaRIIIb (CD16)-induced Ca2+ transients. J Biol Chem (1998) 0.88

The cytoplasmic domain of human FcgammaRIa alters the functional properties of the FcgammaRI.gamma-chain receptor complex. J Biol Chem (1999) 0.87

The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. Ann Rheum Dis (2007) 0.85

Quantitative B-hCG levels less than 1000 mIU/mL in patients with ectopic pregnancy: pelvic ultrasound still useful. J Emerg Med (1998) 0.85

3-hydroxy-3-methylglutaryl coenzyme A reductase in human liver microsomes: active and inactive forms and cross-reactivity with antibody against rat liver enzyme. J Lipid Res (1984) 0.85

Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrom (1986) 0.85

Multivariate correlations of geochemical binding phases of heavy metals in contaminated river sediment. J Environ Sci Health A Tox Hazard Subst Environ Eng (2001) 0.84

Early passive mobilization after digital nerve repair and grafting in a fresh cadaver. Plast Reconstr Surg (2001) 0.84

Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy. Int J Clin Oncol (2001) 0.84

Effect of dietary unsaturated oils on the biosynthesis of cholesterol, and on biliary and fecal excretion of cholesterol and bile acids in rats. J Nutr (1980) 0.83

Mechanisms of tumor necrosis factor cytotoxicity and the cytotoxic signals transduced by the p75-tumor necrosis factor receptor. Circ Shock (1994) 0.82

Species-specific variations in the molecular heterogeneity of the platelet-activating factor. J Immunol (1987) 0.82

Human immunodeficiency virus type 1 (HIV-1) recombinant reverse transcriptase. Asymmetry in p66 subunits of the p66/p66 homodimer. FEBS Lett (1994) 0.82

Partial glyceridase activity of a protein-kinase activatable triglyceride lipase from rat adipose tissue. Biochim Biophys Acta (1972) 0.82

Temperature-induced changes in the hydroxy and non-hydroxy fatty acid-containing sphingolipids abundant in the surface membrane of Tetrahymena pyriformis NT-1. J Lipid Res (1984) 0.80

Titrated propofol induction vs. continuous infusion in children undergoing magnetic resonance imaging. Acta Anaesthesiol Scand (2009) 0.80

Activation of purified 3-hydroxy-3-methylglutaryl-CoA reductase by phospholipids. Biochim Biophys Acta (1977) 0.79

On the mechanism of hypocholesterolemic effects of polyunsaturated lipids. Adv Lipid Res (1980) 0.78

An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem (1994) 0.78

Prevention of cold inactivation of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase by NADPH. Biochim Biophys Acta (1975) 0.78

Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes. J Biol Chem (1986) 0.77

The human stromelysin promoter contains a previously unreported 1.0-kb sequence. Gene (1994) 0.77

Interactions of a photosensitive analog of cholesterol with hydroxymethyglutaryl-CoA reductase (NADPH) and acyl-CoA:cholesterol acyltransferase. Proc Natl Acad Sci U S A (1979) 0.77

Metabolic products of arachidonic acid in rats. Prostaglandins (1985) 0.77

Fatty acid composition of diacyl, alkylacyl, and alkenylacyl phospholipids of control and arachidonate-depleted rat polymorphonuclear leukocytes. J Lipid Res (1987) 0.76

Mapping of the gonadotropin-releasing hormone (GnRH) receptor gene to human chromosome 4q21.2 by fluorescence in situ hybridization. Mamm Genome (1995) 0.76

Tumor necrosis factor receptor genes, TNFR1 and TNFR2, on human chromosomes 12 and 1. Somat Cell Mol Genet (1991) 0.76

Do we practice what we preach? J Clin Rheumatol (1999) 0.75

Retained fecalith: laparoscopic removal. Surg Laparosc Endosc Percutan Tech (2003) 0.75

Ether phospholipids in control and 20:4-depleted rat PMN: additional evidence for a 1-O-alkyl-2-20:4-sn-glycerol-3-phosphocholine specific phospholipase A2. Agents Actions (1987) 0.75

[A study on the risk factors of none-insulin-dependent type diabetes mellitus]. Zhonghua Liu Xing Bing Xue Za Zhi (1998) 0.75

18 tender points and the "18-wheeler" sign: clues to the diagnosis of fibromyalgia. JAMA (1998) 0.75

Use of oligonucleotide arrays to analyze drug toxicity. Ann N Y Acad Sci (2000) 0.75

Combined Fenton-MF process increases acrylonitrile removal. Water Sci Technol (2003) 0.75

Human neutrophil platelet-activating factor: molecular heterogeneity in unstimulated and ionophore-stimulated cells. Biochim Biophys Acta (1987) 0.75

Wet air oxidation of a direct dye solution catalyzed by CoAlPO4 -5. Performance assessment and kinetic study. J Environ Sci Health A Tox Hazard Subst Environ Eng (2001) 0.75

Development of monoclonal antibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Biochem Biophys Res Commun (1982) 0.75

Quantification of phospholipid molecular species by coupled gas chromatography-mass spectrometry of deuterated samples. Anal Biochem (1982) 0.75

Engineering of the human-immunodeficiency-virus-type-1 (HIV-1) reverse transcriptase gene to prevent dimerization of the expressed chimaeric protein: purification and characterization of a monomeric HIV-1 reverse transcriptase. Biotechnol Appl Biochem (1994) 0.75

Surgical correction of prolapse of the male urethra. Vet Med Small Anim Clin (1971) 0.75

Cloning and expression of the human apolipoprotein E gene. Methods Enzymol (1986) 0.75

Endontics in a capuchin monkey: reduction in the length of the canine crown. Vet Med Small Anim Clin (1973) 0.75

Phospholipid molecular species alterations in Tetrahymena ciliary membranes following low-temperature acclimation. Biochemistry (1982) 0.75

Immunotitration of 3-hydroxy-3-methylglutaryl-CoA reductase. Methods Enzymol (1981) 0.75

A rapid and quantitative assay for inhibition of 3' cleavage activity of HIV-1 integrase. Antiviral Res (1997) 0.75

Gout and diabetes; report of a case with severe diabetes and polyarthritic non-tophaceous gout. IMJ Ill Med J (1965) 0.75

The mechanism of membrane response to chilling. Effect of temperature on phospholipid deacylation and reacylation reactions in the cell surface membrane. J Biol Chem (1984) 0.75

Use of a removable maxillary appliance to correct a palatal defect in a dog. Vet Med Small Anim Clin (1971) 0.75

Effect of dietary lipids on the secretion of biliary lipids in rats. Indian J Biochem Biophys (1978) 0.75

Treatment of childhood phimosis with a moderately potent topical steroid. ANZ J Surg (2001) 0.75

Quantitative analysis of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry. Methods Enzymol (1990) 0.75

[Treatment of arteriovenous malformation by linear accelerator radiosurgery]. Zhonghua Wai Ke Za Zhi (1998) 0.75

Separation of a cardiac glycoside from Penstemon grandiflorus. Planta Med (1971) 0.75

Propofol-remifentanil and the ankle clonus test in scoliosis patients. Anaesthesia (2010) 0.75